What kind of biotech start­up wins a $3B syn­di­cate, woos a gallery of mar­quee sci­en­tists and re­cruits GSK's Hal Bar­ron as CEO in a stun­ner? Let Rick Klaus­ner ex­plain

It start­ed with a ques­tion about a life­time’s dream on a walk with tech in­vestor Yuri Mil­ner.

At the be­gin­ning of the great pan­dem­ic, for­mer NCI chief and in­vet­er­ate biotech en­tre­pre­neur Rick Klaus­ner and the Face­book bil­lion­aire would traipse Los Al­tos Hills in Sil­i­con Val­ley Sat­ur­day morn­ings and talk about ideas.

Mil­ner’s ques­tion on one of those morn­ings on foot: “What do you want to do?”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER